Condition: Percutaneous Coronary Intervention · Peripheral Endovascular Intervention · Sponsor: Duke University
V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an adjunct with statin therapy and on the market to lower LDL-C in high-risk populations.
This description comes directly from the study's public registry record.
Robin Barron-Nelson, RN, MSN · 321-946-2747 · robin.barron-nelson@duke.edu
Jen Holt · +1 919 824 6334 · jen.holt@duke.edu
Always discuss trial participation with your own doctor first.
| Advanced Cardiovascular LLC | Alexander City, Alabama, United States | Recruiting |
| Cardiology, PC | Birmingham, Alabama, United States | Recruiting |
| Heart Center Research, LLC | Huntsville, Alabama, United States | Recruiting |
| Cardiology Associates Research Group | Jonesboro, Arkansas, United States | Recruiting |
| Arkansas Cardiology | Little Rock, Arkansas, United States | Recruiting |
| Pacific Oaks Medical Group | Beverly Hills, California, United States | Recruiting |
| Cardiovascular Institute of San Diego | Chula Vista, California, United States | Recruiting |
| Valley Clinical Trials | Covina, California, United States | Withdrawn |
| Thrive Clinical Research Group | Glendora, California, United States | Recruiting |
| Radin Cardiovascular Medical Group, Inc | Newport Beach, California, United States | Recruiting |
| Valley Clinical Trials, LLC - Flourish Research | Northridge, California, United States | Recruiting |
| Riverside Community Hospital | Riverside, California, United States | Recruiting |
+ 103 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06909565